Drawing for BIOMED B

USPTO serial 87981379

BIOMED B

Reviewed by CopyMark Law Group

Reg. 5829988Status 704Registered
Filing date
Status date
Registration date
Aug 6, 2019
Examiner
BUTLER, MIDGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with BIOMED B?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steve Zemanick

Steve Zemanick Four Reasons Legal8074 E 34th AveDenver, CO 80238United States

Goods and services

ClassDescriptionStatusFirst use
001[ magnesium hydroxide; calcium; iron salts; magnesium citrate ]SECTION 8 - CANCELLED—
005Multi-vitamin preparations; [ vitamin A preparations; ] vitamin and mineral preparations for medical use; vitamin B preparations; vitamin C preparations; vitamin D preparations; vitamin preparations; vitamin supplements; vitamin tablets; vitamins; vitamins and vitamin preparations; botanical supplements for general health and well-being; botanical extracts for the treatment of colds and flu; botanical extracts for the treatment of inflammatory bowel disease and connective tissue diseases; botanical extracts for the treatment of stomach ulcers; herbal and dietary supplements for promoting faster muscle recovery after exercise; herbal supplements for general health and well-being; herbal supplements for the promotion of healthy liver function; herbal supplements for the treatment of cardiovascular diseases; herbal supplements for the treatment of inflammatory diseases, namely, inflammatory bowel diseases and inflammatory connective tissue diseases; herbal supplements for the treatment of the musculoskeletal system, namely, connective tissue diseases, cartilage injuries; herbal supplements for the treatment of the respiratory system; mineral supplements; beta carotene supplements; calcium supplements; dietary supplements for general health and well-being; [ dietary supplements for promoting weight loss; ] herbal supplements for the treatment of arthritis; nutritional supplements for general health and wellbeing; homeopathic remedies for the treatment of anxiety disorders; homeopathic remedies for the treatment of [ colds and flu; antioxidant pills; homeopathic remedies for the treatment of ] inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; mineral salts for medical purposes; folic acid; medicines for alleviating constipation; diarrhea medication; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; preparations for destroying parasites; intestinal disorder medicine for the treatment of irritable bowel syndrome; dietary fiber to aid digestion; gastrointestinal cleaning agents; intestinal disorder medicine for the treatment of ulcerative colitis; anti-viral agents; [ nail fungus treatment preparations; fungal medications; ] allergy medications; nasal drops for the treatment of allergies; [ ginseng capsules for general health and well-being; ] anti-inflammatories; anti-inflammatory preparations; anti-tussive expectorants; medicines for the treatment of gastrointestinal diseases; minerals for medical purposes; pain relief medication; diuretics; lipotropic factor preparations; medicines for adjusting the menstrual cycle; antiallergic medicines; nose drops; sleeping pills; preparations for the treatment of burns; acne medications; cough remedy; cough treatment medications; herbal supplements for use in dermatology, namely, dermatitis, eczema, psoriasis; [ homeopathic remedies for treatment of skin conditions, namely, dermatitis, eczema, psoriasis; ] anti-inflammatory and antipyretic preparations; antipyretic preparations; anthelmintics; anti-infectives; antiallergics; antidepressants; antihistamines; [ antimicrobials for dermatologic use; ] antiparasitic preparations; antiparasitics; antispasmodics; antitussives; antivirals; [ biological fungicides; ] botanical extracts for use in the treatment of dermatitis and skin pigmentation diseases; bronchodilating preparations; decongestants; expectorants; fertility enhancement preparations for human use; [ fungicides; fungicides for medical use; ] homeopathic remedies for the treatment of stomach ulcers; intestinal disorder medicine for the treatment of diverticular disease; laxatives; multivitamins; nasal spray preparations; sedatives [ ; vaginal antifungal preparations ]ACTIVE—
041[ Organization of alternative medicine exhibition for educational purposes; organization of seminars, working groups, research groups and conventions, in the field of medicine and stress management; organization of conferences and symposia in the field of medical science and stress management ]SECTION 8 - CANCELLEDMay 23, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 5, 20268.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jun 5, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 4, 2026ES8RTEAS SECTION 8 RECEIVED—
Aug 6, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 6, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 3, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 2, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 2, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 1, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 1, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 19, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2019INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Jun 10, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 28, 2019IUAFUSE AMENDMENT FILED—
May 28, 2019DRRRDIVISIONAL REQUEST RECEIVED—
May 28, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 28, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 28, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 2, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 2, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2018ALIEASSIGNED TO LIE—
Aug 16, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018DOCKASSIGNED TO EXAMINER—
Nov 10, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance